Rifapentine

Last Updated: 04/28/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 713 publications

Outcomes of the three-month weekly isoniazid with rifapentine (3HP) versus the six-month isoniazid preventive therapy (6H) among people newly enrolled in HIV care in western Kenya.

Outcomes of the three-month weekly isoniazid with rifapentine (3HP) versus the six-month isoniazid preventive therapy (6H) among people newly enrolled in HIV care in western Kenya.

Journal: medRxiv : the preprint server for health sciences

Published: March 23, 2026

Rifapentine Dosing for Drug-Susceptible Tuberculosis: Stage 1 of a Seamless Phase 2/3 Randomized Clinical Trial.

Rifapentine Dosing for Drug-Susceptible Tuberculosis: Stage 1 of a Seamless Phase 2/3 Randomized Clinical Trial.

Journal: Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases

Published: January 22, 2026

Determination of nitrite in rifapentine and analysis of the formation causes of nitrosamine impurity.

Determination of nitrite in rifapentine and analysis of the formation causes of nitrosamine impurity.

Journal: Frontiers in chemistry

Published: January 20, 2026

Method Validation of an Ultra-High-Performance Liquid Chromatography (UHPLC) for the Bioequivalence Study of Rifampicin.

Method Validation of an Ultra-High-Performance Liquid Chromatography (UHPLC) for the Bioequivalence Study of Rifampicin.

Journal: Acta medica Philippina

Published: January 15, 2026

Fixed-Dose Rifapentine-Isoniazid (1HP) for Tuberculosis Preventive Treatment in Chinese Adults: A Prospective Real-World Safety and Pharmacokinetic Study.

Fixed-Dose Rifapentine-Isoniazid (1HP) for Tuberculosis Preventive Treatment in Chinese Adults: A Prospective Real-World Safety and Pharmacokinetic Study.

Journal: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America

Published: January 13, 2026

Dolutegravir concentrations in children receiving 3-month weekly isoniazid and rifapentine (3HP) for tuberculosis prevention.

Dolutegravir concentrations in children receiving 3-month weekly isoniazid and rifapentine (3HP) for tuberculosis prevention.

Journal: Microbiology spectrum

Published: January 08, 2026

Pregnancy Outcomes after Exposure to Tuberculosis Treatment in Phase 3 Clinical Trial, 2016-2020.

Pregnancy Outcomes after Exposure to Tuberculosis Treatment in Phase 3 Clinical Trial, 2016-2020.

Journal: Emerging infectious diseases

Published: January 06, 2026

Sodium Alendronate-Modified PLGA-mPEG Nanomicelles Loaded with Rifapentine for Targeted Delivery to Bone Tissue.

Sodium Alendronate-Modified PLGA-mPEG Nanomicelles Loaded with Rifapentine for Targeted Delivery to Bone Tissue.

Journal: Pharmaceutics

Published: December 27, 2025

Clinical characteristics, antimicrobial susceptibility patterns, and treatment outcomes of nontuberculous mycobacterial diseases in eastern China: a retrospective cohort study (2019-2022).

Clinical characteristics, antimicrobial susceptibility patterns, and treatment outcomes of nontuberculous mycobacterial diseases in eastern China: a retrospective cohort study (2019-2022).

Journal: Microbiology spectrum

Published: December 09, 2025

A clinically significant interaction between voriconazole and rifapentine: a case report and review of evidence.

A clinically significant interaction between voriconazole and rifapentine: a case report and review of evidence.

Journal: Frontiers in medicine

Published: December 06, 2025

Quality by Design-Based Development of a Robust LC Method for Simultaneous Estimation of Process- and Degradation-Related Impurities in Rifapentine Drug Product for the Treatment of Active and Latent Tuberculosis.

Quality by Design-Based Development of a Robust LC Method for Simultaneous Estimation of Process- and Degradation-Related Impurities in Rifapentine Drug Product for the Treatment of Active and Latent Tuberculosis.

Journal: Biomedical chromatography : BMC

Published: November 25, 2025

Beyond Rifampin: Evaluating Rifapentine and Rifabutin as Alternative Treatments for TB Meningitis.

Beyond Rifampin: Evaluating Rifapentine and Rifabutin as Alternative Treatments for TB Meningitis.

Journal: The Journal of infectious diseases

Published: November 06, 2025

Showing 1-12 of 713

Last Updated: 04/28/2026